Pharmacology of a selective cyclooxygenase-2 inhibitor, HN-56249: a novel compound exhibiting a marked preference for the human enzyme in intact cells
Berg, J, Fellier, H, Christoph, T, Kremminger, P, Hartmann, M, Blaschke, H, Rovensky, F, Towart, R, Stimmeder, D
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.04.2000)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.04.2000)
Get full text
Journal Article
How to collect blood for the measurement of HGH, LH, FSH, cyclic AMP, folic acid, cortisol and testosterone
Glespach, H., Kreutzer, B., Fellier, H., Borkenstein, M.
Published in Clinica chimica acta (15.10.1977)
Published in Clinica chimica acta (15.10.1977)
Get full text
Journal Article
Tumor host relations. I. Increased plasma cortisol in tumor-bearing humans compared with patients with benign surgical diseases
Schaur, R J, Fellier, H, Gleispach, H, Fink, E, Kronberger, L
Published in Journal of cancer research and clinical oncology (12.04.1979)
Published in Journal of cancer research and clinical oncology (12.04.1979)
Get more information
Journal Article
Antiplatelet and Anticoagulant Effects of “HN-11 500,” a Selective Thromboxane Receptor Antagonist
Schenk, Joachim F, Radziwon, Piotr, Fellier, Harald, Breddin, Hans K
Published in Thrombosis research (15.07.2001)
Published in Thrombosis research (15.07.2001)
Get full text
Journal Article